ePRO Solutions
-
ePRO And Castor Connect
3/19/2024
Gather data directly from the patient—the true source. Empower your team to streamline data collection, making it faster and easier for everyone involved.
-
eCOA / ePRO
9/16/2024
Empower participants, clinicians, and observers. Enable convenient and accurate outcome reporting, enhancing data quality and study efficiency with electronic patient reported outcomes (ePRO) and electronic clinical outcome assessments (eCOA).
-
MRN Technologies
11/22/2024
Our research is powered by MRN owned, regulatory-approved and validated eClinical software systems. Our technology can be used at-site and at-home enabling fully integrated data through any clinical trial.
-
Just The Facts: Direct Data Capture
5/20/2022
Start enabling direct data capture (DDC), clinical outcome assessments (eCOA), patient reported outcomes (ePRO), and eConsent with the Clinical ink platform.
-
ePRO: The Patient Preferred Method Of Data Collection
10/13/2022
ePRO has proven to increase compliance, reduce patient burden, and with Medrio’s seamless EDC integration you can be sure your data is more accurate, complete, and secure.
-
Decentralized Clinical Trials: The Future Of Clinical Research
9/26/2022
Our integrated EDC platform, including eConsent, ePRO, RTSM, and DDC, is your gateway to decentralized trials.
-
End-To-End Digital Therapeutics Studies Powered By Technology
2/2/2023
Curebase offers a variety of decentralized study models designed and tested for any type of DTx trial.
-
Eliminate Barriers To Cancer Research With Clinical Ink ePRO
5/16/2023
Remove the burdens and barriers inherent in clinical trial participation and deliver a more patient-centric experience with Clinical ink’s ePRO.
-
Veeva eCOA Features Brief
6/24/2024
Ensure access and transparency throughout clinical studies while streamlining the design, management, and completion of electronic Clinical Outcome Assessments with Veeva eCOA.
-
End-To-End Diagnostic Studies Powered By Technology
12/16/2022
Learn why Curebase is the only partner you need to run faster, more efficient real-world diagnostics studies from start to finish.